VLS Retatrutide 20mg Pen – Balanced GLP-1/GIP/Glucagon Trifecta for Fat Loss

VLS Retatrutide 20mg Pen is a potent trifecta agonist targeting GLP-1, GIP, and Glucagon receptors. Manufactured by Vitality Life Science (VLS), this innovative peptide pen is engineered for advanced research into metabolic enhancement, fat burning, and glycemic regulation.

With a 20mg concentration delivered via a precision pen, VLS Retatrutide offers mid-level dosing ideal for studies requiring convenience and control. Produced in GMP-certified labs, this peptide is trusted for consistency and safety in pre-clinical settings.

Key Features:

• Triple agonist: GLP-1, GIP, and Glucagon pathways
• 20mg pen for moderate dosing flexibility
• Developed by VLS – UK-based peptide lab
• Supports fat oxidation, appetite suppression, and glucose balance

How to Use VLS Retatrutide Pen:
Form: Ready-to-use injectable pen

Dosage: Begin with 0.25 mg weekly, increasing gradually to 1.5–3.0 mg

Cycle Length: 8–12 weeks, followed by a tapering phase

Administration: Subcutaneous injection, once weekly

How It Works:

• GLP-1 Receptor Activation: Reduces appetite and improves insulin sensitivity
• GIP Activation: Enhances insulin secretion and lipid metabolism
• Glucagon Stimulation: Promotes energy expenditure and fat burning

Recommended Stacks:
Pair With:

Synedica Tirzepatide or Alluvi Retatrutide for synergistic fat-loss support